Price
No data yet.
Social Signal Score
Revenue
$6.64B+86.92%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Adam Luke Hall
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Employees
- 5,700
- Beta
- 0.15
- Country
- AU
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 4.17
Financials
Revenue
$6.64B+86.9%Net Income
$122.53M+95.9%EBITDA
$263.57M+139.9%Free Cash Flow
$-15.82M-121.9%EPS (diluted)
$2.40+46.3%Shares Outstanding (diluted)
51.41M+35.4%Operating Expenses
$281.57MCash & Debt
$250.05MReturn of Capital
$63.99MDividend per Share
$0.68Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2024 | $12.20B | $213.89M | $4.36 |
| 2023 | $13.15B | $270.67M | $5.64 |
| 2022 | $12.25B | $256.54M | $5.32 |
| 2021 | $10.77B | $213.59M | $4.60 |
| 2020 | $9.21B | $185.54M | $4.52 |
| 2019 | $9.38B | $163.27M | $4.02 |
| 2018 | $6.93B | $137.71M | $3.60 |
| 2017 | $7.00B | $137.59M | $3.62 |
| 2016 | $7.27B | $126.66M | $1.68 |
| 2015 | $7.10B | $127.00M | $3.36 |
| 2014 | $6.07B | $105.94M | $1.64 |
| 2013 | $5.76B | $92.07M | $1.26 |
| 2012 | $1.82B | $28.21M | $0.90 |
| 2011 | $1.43B | $27.95M | $0.90 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from EBOSY's reported EPS growth of 12.9% a year over 13 years.
- EPS in 5 years
- $8.00
- Implied price
- $128.07
- Return from $26.00
- 37.6% a year
To earn 15.0% a year on these assumptions you'd need to buy at $63.67 — today's price is already 59.2% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 14 | 16 | 18 | 20 |
|---|---|---|---|---|---|
| 2.9% | 18.4% | 22.1% | 25.4% | 28.4% | 31.1% |
| 7.9% | 24.1% | 28.0% | 31.5% | 34.6% | 37.5% |
| 12.9% | 29.9% | 33.9% | 37.6% | 40.8% | 43.8% |
| 17.9% | 35.6% | 39.9% | 43.7% | 47.1% | 50.2% |
| 22.9% | 41.4% | 45.8% | 49.7% | 53.3% | 56.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
120Social Signal Score
Mentions (1)
- Newsseekingalpha.com·5h ago·Positive
EBOS Group Limited (EBOSY) Q4 2026 Earnings Call Transcript EBOS Group Limited (EBOSY) Q4 2026 Earnings Call Transcript
View source ↗